America's health care system has become too complex and costly to continue business as usual, says a new report from the Institute of Medicine. Inefficiencies, an overwhelming amount of data, and other economic and quality ...
Sep 6, 2012
0
0
Despite the legalization of cannabis sales in Canada and many U.S. states, an illegal market still exists. A new study in the Journal of Studies on Alcohol and Drugs suggests that higher prices and inconvenience associated ...
May 24, 2022
0
1
On May 31, 2021, professional tennis player Naomi Osaka withdrew from the French Open, revealing a battle with long-term depression that left her unwilling to take part in mandatory media commitments. A few weeks later, American ...
Sep 13, 2022
0
16
New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.
Jul 2, 2013
2
0
The success of an innovative design app competition, organised through our Centre for Pain Research, is cited in a recent Parliamentary Report on advances into assistive technology that could help the elderly and people living ...
Aug 29, 2014
0
0
Imagine a championship match between two rival basketball teams. The game is tied, seconds left on the shot clock, two players lunge forward, reaching for the ball. In a split second, their hands both collide with the ball, ...
Apr 26, 2019
0
1
Scientists love a challenge. Or a friendly competition. Now, scientists at La Jolla Institute for Immunology (LJI) have recently published the results of a competition that put researchers to the test. For the competition, ...
Mar 14, 2024
0
13
(AP)—Eli Lilly and Co. said Friday its 2013 earnings will grow more than Wall Street expects, even though the drugmaker will lose U.S. patent protection for two more key products this year.
Jan 4, 2013
0
0
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Aug 7, 2012
0
0
Merck & Co. said Monday that its third-quarter profit plunged 35 percent because of competition from generic drugs, lower sales of its top-selling medicine, and restructuring and acquisition charges. It still beat Wall Street's ...
Oct 28, 2013
0
0
